Topical ointment therapy benefits premature infants

Area of Science:

• Neonatal dermatology
• Neonatal intensive care
• Dermatology

Background:

• Premature infants possess an immature epidermal barrier, increasing susceptibility to infections and complications.
• Effective management of the neonatal skin barrier is crucial for infant health and development.

Purpose of the Study:

• To evaluate the impact of preservative-free topical ointment therapy on skin barrier function and systemic health in premature infants.
• To assess the effects of this therapy on transepidermal water loss (TEWL), skin condition, bacterial colonization, and infection rates.

Main Methods:

• A prospective, randomized study involving 60 premature infants (less than 33 weeks' gestational age).
• Treatment group received twice-daily preservative-free topical ointment for 2 weeks; control group received standard care.
• Data collected included TEWL, skin condition, microbial cultures (skin, blood, CSF), fluid balance, and weight changes.

Main Results:

• Topical ointment significantly reduced TEWL for up to 6 hours post-application.
• Improved skin condition scores and reduced bacterial colonization in the axilla were observed in the treated group.
• The incidence of positive blood and/or cerebrospinal fluid cultures was significantly lower in infants receiving ointment therapy (3.3% vs. 26.7%).

Conclusions:

• Preservative-free topical ointment therapy effectively enhances the epidermal barrier in premature infants.
• This therapy reduces skin barrier dysfunction, bacterial colonization, and the risk of serious infections.
• The findings support the routine use of preservative-free topical ointments in very premature infants during the early neonatal period.